| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | Cell_morpho_N | 4.70e-06 | 2 | 41 | 2 | IPR025614 | |
| Domain | MOR2-PAG1_mid | 4.70e-06 | 2 | 41 | 2 | IPR029473 | |
| Domain | MOR2-PAG1_mid | 4.70e-06 | 2 | 41 | 2 | PF14228 | |
| Domain | MOR2-PAG1_C | 4.70e-06 | 2 | 41 | 2 | PF14225 | |
| Domain | MOR2-PAG1_N | 4.70e-06 | 2 | 41 | 2 | PF14222 | |
| Domain | Cell_Morphogen_C | 4.70e-06 | 2 | 41 | 2 | IPR025481 | |
| Domain | zf-C2H2_6 | 4.89e-06 | 314 | 41 | 7 | PF13912 | |
| Domain | - | 1.30e-05 | 679 | 41 | 9 | 3.30.160.60 | |
| Domain | zf-C2H2 | 1.53e-05 | 693 | 41 | 9 | PF00096 | |
| Domain | Znf_C2H2/integrase_DNA-bd | 1.54e-05 | 694 | 41 | 9 | IPR013087 | |
| Domain | ZINC_FINGER_C2H2_2 | 3.69e-05 | 775 | 41 | 9 | PS50157 | |
| Domain | ZINC_FINGER_C2H2_1 | 3.77e-05 | 777 | 41 | 9 | PS00028 | |
| Domain | Znf_C2H2-like | 4.55e-05 | 796 | 41 | 9 | IPR015880 | |
| Domain | Znf_C2H2 | 4.96e-05 | 805 | 41 | 9 | IPR007087 | |
| Domain | ZnF_C2H2 | 5.11e-05 | 808 | 41 | 9 | SM00355 | |
| Domain | FAT | 7.01e-05 | 6 | 41 | 2 | PS51189 | |
| Domain | FATC | 7.01e-05 | 6 | 41 | 2 | PS51190 | |
| Domain | FAT | 7.01e-05 | 6 | 41 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 7.01e-05 | 6 | 41 | 2 | IPR003151 | |
| Domain | FATC_dom | 7.01e-05 | 6 | 41 | 2 | IPR003152 | |
| Domain | PIK_FAT | 7.01e-05 | 6 | 41 | 2 | IPR014009 | |
| Domain | FATC | 7.01e-05 | 6 | 41 | 2 | SM01343 | |
| Domain | KRAB | 1.21e-04 | 358 | 41 | 6 | PS50805 | |
| Domain | KRAB | 1.43e-04 | 369 | 41 | 6 | SM00349 | |
| Domain | KRAB | 1.45e-04 | 370 | 41 | 6 | IPR001909 | |
| Domain | - | 5.53e-04 | 16 | 41 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 5.53e-04 | 16 | 41 | 2 | SM00146 | |
| Domain | PI3/4_kinase_cat_dom | 7.04e-04 | 18 | 41 | 2 | IPR000403 | |
| Domain | PI3_PI4_kinase | 7.04e-04 | 18 | 41 | 2 | PF00454 | |
| Domain | PI3_4_KINASE_3 | 7.04e-04 | 18 | 41 | 2 | PS50290 | |
| Domain | PI3_4_KINASE_1 | 7.04e-04 | 18 | 41 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 7.04e-04 | 18 | 41 | 2 | PS00916 | |
| Domain | DAG/PE-bd | 9.62e-04 | 21 | 41 | 2 | IPR020454 | |
| Domain | KRAB | 1.07e-03 | 358 | 41 | 5 | PF01352 | |
| Domain | - | 5.60e-03 | 51 | 41 | 2 | 3.10.110.10 | |
| Domain | UBQ-conjugating_enzyme/RWD | 6.04e-03 | 53 | 41 | 2 | IPR016135 | |
| Domain | ARM-type_fold | 6.36e-03 | 339 | 41 | 4 | IPR016024 | |
| Domain | C1_1 | 6.95e-03 | 57 | 41 | 2 | PF00130 | |
| Domain | ZF_DAG_PE_1 | 8.70e-03 | 64 | 41 | 2 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 8.70e-03 | 64 | 41 | 2 | PS50081 | |
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 14596936 | ||
| Pubmed | Lack of ADAM2, CALR3 and SAGE1 Cancer/Testis Antigen Expression in Lung and Breast Cancer. | 4.48e-06 | 3 | 43 | 2 | 26252478 | |
| Pubmed | 4.48e-06 | 3 | 43 | 2 | 12014986 | ||
| Pubmed | Distinct roles of c-Abl and Atm in oxidative stress response are mediated by protein kinase C delta. | 8.94e-06 | 4 | 43 | 2 | 15289456 | |
| Pubmed | Negative regulation of autophagy by UBA6-BIRC6-mediated ubiquitination of LC3. | 1.49e-05 | 5 | 43 | 2 | 31692446 | |
| Pubmed | 1.49e-05 | 5 | 43 | 2 | 16651613 | ||
| Pubmed | 3.12e-05 | 7 | 43 | 2 | 15887267 | ||
| Pubmed | 3.12e-05 | 7 | 43 | 2 | 12628935 | ||
| Pubmed | Role of the translocation partner in protection against AID-dependent chromosomal translocations. | 4.16e-05 | 8 | 43 | 2 | 19966290 | |
| Pubmed | Tel2 regulates the stability of PI3K-related protein kinases. | 6.68e-05 | 10 | 43 | 2 | 18160036 | |
| Pubmed | Tti1 and Tel2 are critical factors in mammalian target of rapamycin complex assembly. | 8.15e-05 | 11 | 43 | 2 | 20427287 | |
| Pubmed | Activator-Mediator binding regulates Mediator-cofactor interactions. | 8.15e-05 | 11 | 43 | 2 | 20534441 | |
| Pubmed | 8.39e-05 | 591 | 43 | 6 | 15231748 | ||
| Pubmed | HIV-1 Tat and AIDS-associated cancer: targeting the cellular anti-cancer barrier? | 9.78e-05 | 12 | 43 | 2 | 18577246 | |
| Pubmed | 9.78e-05 | 12 | 43 | 2 | 29786085 | ||
| Pubmed | 1.15e-04 | 13 | 43 | 2 | 25178676 | ||
| Pubmed | 1.35e-04 | 14 | 43 | 2 | 21079677 | ||
| Pubmed | 1.74e-04 | 87 | 43 | 3 | 12465718 | ||
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 2.94e-04 | 104 | 43 | 3 | 31240132 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 3.59e-04 | 497 | 43 | 5 | 36774506 | |
| Pubmed | PEA15 regulates the DNA damage-induced cell cycle checkpoint and oncogene-directed transformation. | 4.05e-04 | 24 | 43 | 2 | 24710276 | |
| Pubmed | 4.37e-04 | 1497 | 43 | 8 | 31527615 | ||
| Pubmed | MxA interacts with and is modified by the SUMOylation machinery. | 5.14e-04 | 27 | 43 | 2 | 25447205 | |
| Pubmed | Generation of functional multipotent adult stem cells from GPR125+ germline progenitors. | 6.35e-04 | 30 | 43 | 2 | 17882221 | |
| Pubmed | Gene-smoking interactions identify several novel blood pressure loci in the Framingham Heart Study. | 7.23e-04 | 32 | 43 | 2 | 25189868 | |
| Pubmed | 1.23e-03 | 653 | 43 | 5 | 22586326 | ||
| Interaction | PPRC1 interactions | 1.01e-05 | 21 | 41 | 3 | int:PPRC1 | |
| Interaction | LTBP2 interactions | 2.65e-05 | 85 | 41 | 4 | int:LTBP2 | |
| Cytoband | 8p11.2 | 7.74e-05 | 14 | 43 | 2 | 8p11.2 | |
| Cytoband | 19p12 | 8.49e-05 | 90 | 43 | 3 | 19p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p12 | 2.09e-04 | 122 | 43 | 3 | chr19p12 | |
| Cytoband | 11q25 | 2.75e-04 | 26 | 43 | 2 | 11q25 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p11 | 4.24e-03 | 103 | 43 | 2 | chr8p11 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.14e-06 | 718 | 29 | 9 | 28 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Lymphocytic-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 170 | 43 | 4 | 3ad9f950b87ee98f025ab9b4a8ed551e6a9b4764 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 3.21e-05 | 188 | 43 | 4 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 3.55e-05 | 193 | 43 | 4 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | Macroglial-Oligodendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.08e-05 | 200 | 43 | 4 | 4dbac2f2587e87ca5a0622f50439bb5447e93c7f | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.08e-05 | 200 | 43 | 4 | 1314664c1721e9ecb1e2c3482a039044b0fe50a9 | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.08e-05 | 200 | 43 | 4 | 8b229f095fc113aecfc94b64862a9e0fdcc363ce | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.08e-05 | 200 | 43 | 4 | 272909f4354f3ae22e2b2f8f35970e6b0e92cfe2 | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.08e-05 | 200 | 43 | 4 | 26b989e30bbbaf30904ced03f6aae3dea25c732c | |
| ToppCell | Macroglial-Oligodendrocytes-OPALIN|Macroglial / cells hierarchy compared to all cells using T-Statistic | 4.08e-05 | 200 | 43 | 4 | 5f75a9b8bcd49d9bbb1e9ce2de730eaec96369ca | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-04 | 149 | 43 | 3 | defe2e4a2f3118f8b42e99a4f2bf03e54c1b698f | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_3|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 4.47e-04 | 155 | 43 | 3 | 335cd798afbaa0a3a3e1dc558a81cfa32da48983 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.82e-04 | 159 | 43 | 3 | 1472536eea61d4f13033efe42f128bae1614fa74 | |
| ToppCell | facs-Marrow-T-cells-24m-Hematologic-MPP_Fraction_B|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.91e-04 | 160 | 43 | 3 | b3f7ef7e682b48a83ca425f5c439336e96168300 | |
| ToppCell | critical-Epithelial-unknown_epithelial|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.00e-04 | 161 | 43 | 3 | 594cf3245ec065a7685db81cd8ba2cee8d42caac | |
| ToppCell | Mild-MAIT|Mild / Disease group and Cell class | 5.00e-04 | 161 | 43 | 3 | 0c1a04485708d5302600cdc2d7dac1cb76b4033a | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.00e-04 | 161 | 43 | 3 | 5fba13f0aa5002f7eefe219e2c6a07e163f1a50d | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-T_cells-TRGV2_gdT|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.18e-04 | 163 | 43 | 3 | 004765e016c5658ee4a8bda4899804303064727b | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.18e-04 | 163 | 43 | 3 | 0ab043b68e8739adcedda01165a3758cd0d22728 | |
| ToppCell | CV-Mild-3|Mild / Virus stimulation, Condition and Cluster | 5.46e-04 | 166 | 43 | 3 | 5599f90fc0e15a3670b03187085eba91228390a2 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-C_(Myofibroblast)|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.66e-04 | 168 | 43 | 3 | 1bc6a1915d48f547385ed4f44e118bcc8a4a7b6c | |
| ToppCell | 368C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 5.66e-04 | 168 | 43 | 3 | 69f534de0f9a293047bea03cb1b78551087a8df5 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.66e-04 | 168 | 43 | 3 | c66a61d3ec711796313a2c6d2dc39aedbfc20afd | |
| ToppCell | 368C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.66e-04 | 168 | 43 | 3 | 83b4f817d95daa15ae60668e789f97d8a3b2e6dd | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein-D175|Adult / Lineage, Cell type, age group and donor | 5.75e-04 | 169 | 43 | 3 | e1f0298236e4a1c59077c14f0dd29a78fac12648 | |
| ToppCell | 343B-Lymphocytic-NK_cells-Proliferating_NK_cell|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.75e-04 | 169 | 43 | 3 | 02fa66a91b8bd2bf971aec4f5ec58318b5bfdf14 | |
| ToppCell | normal_Lung-Fibroblasts-Pericytes|Fibroblasts / Location, Cell class and cell subclass | 5.85e-04 | 170 | 43 | 3 | d69c0ea4cb6b204f19d0a5d2164afb42184779ac | |
| ToppCell | NS-critical-d_16-33-Epithelial-unknown_epithelial|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.06e-04 | 172 | 43 | 3 | c0b5e4889aef2f168d9f6db19a63b24bfd249316 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_104|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.16e-04 | 173 | 43 | 3 | 176d7dc103b8161c4e2d7dc74f2dc77ea1f2d2ed | |
| ToppCell | critical-Epithelial-unknown_epithelial|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.16e-04 | 173 | 43 | 3 | 4144b1cdefa8c37b6ac7a6d249fa5292ffb2b8b2 | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.37e-04 | 175 | 43 | 3 | 711ace94fa9a763c6ae48171a690953f25deebe4 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.58e-04 | 177 | 43 | 3 | 8e4005fad50e6f919da175f3b9ae58849dbd60b1 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.69e-04 | 178 | 43 | 3 | f02076ece0fa899e620971c887ad4da7f48684ed | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.69e-04 | 178 | 43 | 3 | 6178706db4a855d72abc156537604d575624df56 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_NK-T_NK-ILC_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.80e-04 | 179 | 43 | 3 | d18a520568cf4b031972d3dd7d4d4bd073ac1fea | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.91e-04 | 180 | 43 | 3 | 1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.02e-04 | 181 | 43 | 3 | 2c660fcf0404c155955b67ab2958d6e6b0e30024 | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_B2|356C / Donor, Lineage, Cell class and subclass (all cells) | 7.13e-04 | 182 | 43 | 3 | 52baef8173df0a55307c375674a37c2488066738 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.48e-04 | 185 | 43 | 3 | 406b52516b26e9fe2c9e768950af447ec7ad5f3e | |
| ToppCell | metastatic_Brain-Endothelial_cells-Stalk-like_ECs|metastatic_Brain / Location, Cell class and cell subclass | 7.48e-04 | 185 | 43 | 3 | ad52970e88e8947ef256095bd4b40229b912d58a | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD4-positive,_alpha-beta_T_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.48e-04 | 185 | 43 | 3 | f2ebd099c8dfcfaca4298bcdd618c50701a9c2c8 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_T-T_NK-CD4_T_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.48e-04 | 185 | 43 | 3 | 32f43ddc8a899827924834546db33928e353271b | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.48e-04 | 185 | 43 | 3 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-lymphocytic-innate_lymphocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.60e-04 | 186 | 43 | 3 | fc0b488c201a32d829047b58460297df2818b45d | |
| ToppCell | COVID-19_Convalescent-PLT_4|World / Disease Group and Platelet Clusters | 7.60e-04 | 186 | 43 | 3 | 5954a1e3ffafb33f2a9bc87af3343f304fda4c92 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.60e-04 | 186 | 43 | 3 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | Nasal_Brush-Immune-Neutrophils|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.60e-04 | 186 | 43 | 3 | f5aa91dbef29f7efa2b9a728c6539d7541340cd4 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.60e-04 | 186 | 43 | 3 | 85787ff207f109ec7e3c0f729ba9bda739c2fdc9 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_C|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.72e-04 | 187 | 43 | 3 | 1e8651e6c547384ace5a66b96c6b24a7f390a7ee | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.72e-04 | 187 | 43 | 3 | 6981b856187a2e689260ecb7d0a1193a374ee9b9 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.72e-04 | 187 | 43 | 3 | 86250acf088ec0c4800a0dfa031b0d4f7e52c342 | |
| ToppCell | COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 7.72e-04 | 187 | 43 | 3 | 2d20193a6cacdfa4877457c97b0077408942186c | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.84e-04 | 188 | 43 | 3 | 117dc80fa940e6aa1b0187a43fdde33f3fcb578f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.84e-04 | 188 | 43 | 3 | ccddc08121caff958a2b6f9e278a018858af6b4d | |
| ToppCell | COPD-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 7.84e-04 | 188 | 43 | 3 | 1aa0e35b1c28ac847886fece16c3ef7fc6fcdd51 | |
| ToppCell | (0)_NK_CD160pos|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 7.96e-04 | 189 | 43 | 3 | 713991025bb92d38cb0507ff01fd91b48c8af45a | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.96e-04 | 189 | 43 | 3 | b6b4da51bc7f2c13a2f940540fdc61027d084835 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.96e-04 | 189 | 43 | 3 | b4b93bd10b7e3cc16e54ff73beac230f519c010a | |
| ToppCell | facs-BAT-Fat-3m|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.96e-04 | 189 | 43 | 3 | 7ce71f9c81512ed38c804f025908746b4af3aab1 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.08e-04 | 190 | 43 | 3 | 9ce7df056bfb24d70db4c3c4a2c57d89115de877 | |
| ToppCell | Nasal_Brush-Epithelial-Ciliated_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.08e-04 | 190 | 43 | 3 | 833481ace2800354712e2ce709d5cdfd0aed3d42 | |
| ToppCell | COVID-19-lung-Artery_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.08e-04 | 190 | 43 | 3 | 07b675befcd1d0a9c90cb17b5d22323468325d51 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_NK-T_NK-CD56_bright_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.08e-04 | 190 | 43 | 3 | 251d50a77e5118a9ad19ea01a7c7c862230ed63c | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.20e-04 | 191 | 43 | 3 | df8cdbc26443e55a203cbafa21b0952a2a55b9bf | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.33e-04 | 192 | 43 | 3 | 63e815664b228575886396387d2738cd73855759 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_NK-T_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.33e-04 | 192 | 43 | 3 | 095151a4f878944835945f698aa0e3b540ffc8c3 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 8.33e-04 | 192 | 43 | 3 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | moderate-Lymphoid-Treg|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.33e-04 | 192 | 43 | 3 | e370ff5aaff7b7042ba9aaf93de43aa563b8b9f9 | |
| ToppCell | ASK452-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 8.45e-04 | 193 | 43 | 3 | c0d10075862ac878aa05fc49c8b73e470783bf16 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.45e-04 | 193 | 43 | 3 | 3f8280ef849d95b2fcea5e6824b95a07febc96d0 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.45e-04 | 193 | 43 | 3 | 41ea268e7697101fe70d8ef1045f3a43b9311739 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.45e-04 | 193 | 43 | 3 | b2abe939027a69b60d83a28d4d4cc53ba1dee4c5 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.45e-04 | 193 | 43 | 3 | 87ce81ff5b27d9c4300826d76ff5a62e9c408d5d | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.45e-04 | 193 | 43 | 3 | d75f334fe3d9f39ef02a5de0f8202f7a761a8fc8 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.45e-04 | 193 | 43 | 3 | cd45118ced91b10baed3b1068d4673ec99824b86 | |
| ToppCell | Control-Fibroblasts-Vascular_smooth_muscle|Control / group, cell type (main and fine annotations) | 8.45e-04 | 193 | 43 | 3 | 60e44aac8be0430ad35e20eb98b1b700d76a0427 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Vein|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.45e-04 | 193 | 43 | 3 | 7261c1ce30c796b61c6ec58e64a051baa24732ff | |
| ToppCell | Int-URO-Lymphocyte-T_NK-NK|Int-URO / Disease, Lineage and Cell Type | 8.45e-04 | 193 | 43 | 3 | 5c7942f630fc69374df34ee3602ad973b6ced17a | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-T_cells-Activated_T|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.58e-04 | 194 | 43 | 3 | e3705346755cbf65fc276d4d4fbee936ed6bb7bf | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.58e-04 | 194 | 43 | 3 | 7a7ddccfe72a4a0dc4d1a5c809988f0069f9f1a3 | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-NK|Leuk-UTI / Disease, Lineage and Cell Type | 8.58e-04 | 194 | 43 | 3 | 36afc4e48d267be3b8aa1e33fad043bcd54c6bc5 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.58e-04 | 194 | 43 | 3 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | ASK452-Epithelial-Ciliated|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 8.58e-04 | 194 | 43 | 3 | 5aeb44657ab6f61b1abf98af28d3397d8e44c1aa | |
| ToppCell | 10x5'-Liver-Lymphocytic_NK|Liver / Manually curated celltypes from each tissue | 8.58e-04 | 194 | 43 | 3 | 0b78f4ed84bbaca9f72f005c16c7492bb01d4328 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.58e-04 | 194 | 43 | 3 | 40842a7160f337bfc191ee15fbda3e3d38a04c57 | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.58e-04 | 194 | 43 | 3 | b4ce60c06568123008b1081d644733cb91c28f51 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.58e-04 | 194 | 43 | 3 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | 3'-Distal_airway-Mesenchymal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.58e-04 | 194 | 43 | 3 | f5e3e675187afb6efa774f2a8d685efcf813de82 | |
| ToppCell | COVID-19-lung-Pericytes/_Smooth_Muscle|lung / Disease (COVID-19 only), tissue and cell type | 8.58e-04 | 194 | 43 | 3 | 5e1e0513a54ec4cf0b247ec85c9fbc68dfac1da3 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.71e-04 | 195 | 43 | 3 | 609732e83ab7fc3ba7dace66f5a17e46557fd6d1 | |
| ToppCell | 10x5'-Lung-Lymphocytic_NK-NK_CD16|Lung / Manually curated celltypes from each tissue | 8.71e-04 | 195 | 43 | 3 | e91e7f89163c615b706f3297b641b1e4c966f5e6 | |
| ToppCell | NS-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.71e-04 | 195 | 43 | 3 | 34e37cff4849696ca4ba5dd8fd2cf98fed8bc912 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.71e-04 | 195 | 43 | 3 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.71e-04 | 195 | 43 | 3 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | BL-critical-LOC-Epithelial-Ciliated|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.71e-04 | 195 | 43 | 3 | 07a6bcef6af93ed87df455dee624037cb75e011a | |
| ToppCell | 10x5'-Lung-Lymphocytic_NK|Lung / Manually curated celltypes from each tissue | 8.71e-04 | 195 | 43 | 3 | a5a10ef9254c266316e5591bec19e159cc3caead | |
| ToppCell | 10x5'|World / Manually curated celltypes from each tissue | 8.71e-04 | 195 | 43 | 3 | de28b998793271c4f69ce9e183c3e62d809e9cc8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.84e-04 | 196 | 43 | 3 | 889c9fed857f64664ca1f47fcec9fecb15ed103c | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.84e-04 | 196 | 43 | 3 | bd251231288c900b23d3a676ceec6ac07d228917 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated-diff|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.84e-04 | 196 | 43 | 3 | 9a91a6e5f93ce3bb5a0fc63677553f4c2df95c43 | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-MK-early_MK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.84e-04 | 196 | 43 | 3 | fc541e328aed28e84d5b3835169c60da0d64cddc | |
| Disease | alcoholic liver disease | 2.20e-04 | 82 | 42 | 3 | EFO_0008573 | |
| Disease | S-6-hydroxywarfarin to S-warfarin ratio measurement | 2.70e-04 | 88 | 42 | 3 | EFO_0803332 | |
| Disease | prostate carcinoma in situ (is_marker_for) | 7.30e-04 | 28 | 42 | 2 | DOID:8634 (is_marker_for) | |
| Disease | pack-years measurement, systolic blood pressure | 1.08e-03 | 34 | 42 | 2 | EFO_0006335, EFO_0006526 | |
| Disease | renal cell carcinoma | 1.64e-03 | 42 | 42 | 2 | EFO_0000681 | |
| Disease | nasopharynx carcinoma (is_marker_for) | 1.72e-03 | 43 | 42 | 2 | DOID:9261 (is_marker_for) | |
| Disease | Gastric Adenocarcinoma | 1.88e-03 | 45 | 42 | 2 | C0278701 | |
| Disease | Gastrointestinal Stromal Sarcoma | 2.05e-03 | 47 | 42 | 2 | C3179349 | |
| Disease | Gastrointestinal Stromal Tumors | 2.32e-03 | 50 | 42 | 2 | C0238198 | |
| Disease | mean platelet volume | 3.04e-03 | 1020 | 42 | 6 | EFO_0004584 | |
| Disease | protein-glutamine gamma-glutamyltransferase e measurement | 3.32e-03 | 60 | 42 | 2 | EFO_0020690 | |
| Disease | rheumatoid arthritis, COVID-19 | 3.77e-03 | 64 | 42 | 2 | EFO_0000685, MONDO_0100096 | |
| Disease | Benign Neoplasm | 4.25e-03 | 68 | 42 | 2 | C0086692 | |
| Disease | Neoplasms | 4.25e-03 | 68 | 42 | 2 | C0027651 | |
| Disease | melanoma | 5.29e-03 | 248 | 42 | 3 | C0025202 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FKEVIHKHFYLKRVE | 4751 | Q9NR09 | |
| FEKTIHFYQKKIILH | 411 | Q96RT6 | |
| HFYQKKIILHEKKAH | 416 | Q96RT6 | |
| IKKVHVILHFKNKYH | 141 | Q96L12 | |
| FEHVIYQVKHKKADV | 136 | Q99965 | |
| YAVKKHFALHKTLEF | 316 | Q16706 | |
| AKIHYIKNHEFIATF | 151 | Q05655 | |
| VLNLAFKHFKHKEGY | 151 | O94915 | |
| IVIFIHYKSAKHIKE | 1836 | Q8TDM6 | |
| VKKHVRSFHSEKIYQ | 631 | Q9NQV6 | |
| NVYKKHRILKIYHLF | 1431 | Q13315 | |
| YKKAVKYVHSSQHVI | 381 | Q9P2K1 | |
| NIQKDYVFKLHFKSH | 991 | Q9Y4F1 | |
| KYVKQEVKEALAHHF | 86 | P0DJR0 | |
| FKKDYSKVQHLALHA | 281 | Q6PD62 | |
| VNVYHHLVETLKFAK | 316 | P36269 | |
| KSKVHYHVAVIINYL | 111 | P34998 | |
| FQAKLEHEYIHNFKL | 106 | Q15555 | |
| IKHKHILAKNYFSQV | 741 | Q8NA54 | |
| VRHHLKKVNYQKFDT | 551 | Q8N7U6 | |
| IHDVINLAFKHFKYK | 196 | Q5TBA9 | |
| KYEKIHNFKVHTFRG | 201 | P15882 | |
| VILKKKVDFEHQNHY | 316 | Q9H159 | |
| SEYKKKYREHVLQLH | 116 | P59044 | |
| QHFFEYLLVVSLKKK | 51 | Q9H6A0 | |
| KHFQEFHRELLKYKA | 121 | Q13393 | |
| FNYIEKLKYEHHLKE | 161 | Q9H5J8 | |
| FLEFLKKHKSEHVFQ | 266 | Q9UIY3 | |
| HHLQESIFTKEAYKK | 76 | Q9HAU6 | |
| ALFYHFVQIVHKKNV | 91 | P42695 | |
| LYVFVGVKFRTHLKH | 286 | P46094 | |
| KFEKYFNHKALQLLH | 706 | A0AVT1 | |
| YVKVFHKFLNANRHK | 181 | Q8TF32 | |
| LRKHQKFHTEVKYYE | 306 | P52740 | |
| YVKVFHKFLNSNTHK | 181 | Q8NE65 | |
| IFYFKEHERIHTGKK | 311 | Q8NDQ6 | |
| YIKVFHKIFNSNRHK | 121 | Q96N38 | |
| KTFIYKHGLKLHQSL | 686 | O95625 | |
| KKFSLKHQLETHYRV | 581 | Q05516 | |
| VFKQFKYLSVHLKAE | 681 | Q13129 | |
| YVVHEEKKYIHIFLN | 651 | Q7Z6L1 | |
| KRYFIHIKKIFQERH | 656 | Q9BRH9 | |
| VHIYDKAFITVKHRK | 326 | P17948 | |
| IHHFLDFVKQIYKEL | 151 | Q9Y4A5 |